For research use only. Not for therapeutic Use.
CYP19A1/CYP11B2-IN-1 (Compound X21) is a potent and selective aromatase and
aldosterone synthase dual inhibitor with IC50s of 2.3 nM and 29 nM for aromatase (CYP19A1) and aldosterone synthase (CYP11B2), respectively. CYP19A1/CYP11B2-IN-1 has excellent antiproliferative and pro-apoptotic activity against the cancer cell. CYP19A1/CYP11B2-IN-1 can be used for research of breast cancer[1].
CYP19A1/CYP11B2-IN-1 (Compound X21) (0.001-100 μM, 24 h) shows a time- and concentration-dependent proliferation inhibition on MCF-7 and MDA-MB-231 cells[1].
CYP19A1/CYP11B2-IN-1 (700 nM, 24 h) significantly inhibits the phosphorylation of mTOR in MCF-7 cells, thereby negatively modulating the PI3K/Akt/mTOR axis[1].
CYP19A1/CYP11B2-IN-1 (20-30 μM) has no significant inhibition of hERG and Nav1.5, indicating no toxicity to the heart[1].
| Catalog Number | M032813 |
| CAS Number | 183500-36-9 |
| Synonyms | 4-[[5-(hydroxymethyl)imidazol-1-yl]methyl]benzonitrile |
| Molecular Formula | C12H11N3O |
| Purity | ≥95% |
| InChI | InChI=1S/C12H11N3O/c13-5-10-1-3-11(4-2-10)7-15-9-14-6-12(15)8-16/h1-4,6,9,16H,7-8H2 |
| InChIKey | ACFSBQWDVYWNRT-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1CN2C=NC=C2CO)C#N |
| Reference | [1]. Tinivella A, et al. Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase. ACS Pharmacology & Translational Science. 2023 Nov 23. |
